Skip to content

Clinical trials

Basal Cell Carcinoma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Basal Cell Carcinoma Country / region: United States Clear all

160 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20013
20031
20047
20051
20064
20076
20083
20097
20105
20118
20128
20134
20146
20156
20165
20176
20185
20199
20207
202112
20224
20236
20249
20258
20269

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed99
Recruiting21
Active, not recruiting13
Terminated12
Unknown status7
Withdrawn4
Suspended2
Not yet recruiting1
Approved for marketing1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)9
Memorial Sloan Kettering Cancer Center7
Case Comprehensive Cancer Center5
Genentech, Inc.5
Roswell Park Cancer Institute5
UCSF Benioff Children's Hospital Oakland5
Massachusetts General Hospital4
Regeneron Pharmaceuticals4
Stanford University4
University of Arizona4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Basal Cell Carcinoma160
Skin Neoplasms42
Carcinoma, Squamous Cell40
Melanoma31
Basal Cell Nevus Syndrome14
Carcinoma, Merkel Cell14
Cutaneous Squamous Cell Carcinoma14
Neoplasms10
Squamous Cell Carcinoma of Head and Neck8
Breast Neoplasms7

Trials

Showing 1 to 25 of 160. Each trial links to its page on Pharma Observatory.

60 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.